Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Germany (DAX) (EWG) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance

iShares MSCI Germany (DAX)Trade
GE HealthCare Technologies Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Germany (DAX) vs GE HealthCare Technologies Inc. Common Stock — how do they compare? iShares MSCI Germany (DAX) trades at $40.94 (market cap $1.53B), while GE HealthCare Technologies Inc. Common Stock trades at $69.4 (market cap $30.93B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 20.2× iShares MSCI Germany (DAX)'s market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while iShares MSCI Germany (DAX) pays none. Which is the better fit depends on your goals.

EWGGEHC
Market Cap
$1.53B$30.93B
Volume
1,020,5415,033,451
Sector
Broad Market / FactorHealth
52-Week High
$44.59$88.16
52-Week Low
$38.08$59.48
Typical Hold Time
55 Days—
Enterprise Value
—$39.39B
Dividend Yield
—0.23%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Germany (DAX)

EWG trades at $41.20 with a modest 0.59% daily gain, though technical indicators signal a bearish trend with moving averages showing 4 buy versus 9 sell signals. The stock faces resistance at $42 with support at $41. Recent European market focus highlights resilience amid ECB rate hikes and energy price pressures affecting regional equities.

Outlook remains cautious due to bearish technicals and macroeconomic headwinds from ECB tightening. Investment opportunity hinges on European economic stability, but risks include prolonged inflation and energy market volatility. Stock-specific fundamentals are unavailable, requiring deeper due diligence.

GE HealthCare Technologies Inc. Common Stock

GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.

The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.

Returns comparison

Trailing returns across standard periods

About iShares MSCI Germany (DAX)

EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.

Read more on EWG →

About GE HealthCare Technologies Inc. Common Stock

GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.

Read more on GEHC →